Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Delivery of miR-146a to Ly6Chigh Monocytes Inhibits Pathogenic Bone Erosion in Inflammatory Arthritis.

Ammari M, Presumey J, Ponsolles C, Roussignol G, Roubert C, Escriou V, Toupet K, Mausset-Bonnefont AL, Cren M, Robin M, Georgel P, Nehmar R, Taams L, Grün J, Grützkau A, Häupl T, Pers YM, Jorgensen C, Duroux-Richard I, Courties G, Apparailly F.

Theranostics. 2018 Nov 13;8(21):5972-5985. doi: 10.7150/thno.29313. eCollection 2018.

2.

Advanced microRNA-based cancer diagnostics using amplified time-gated FRET.

Qiu X, Xu J, Guo J, Yahia-Ammar A, Kapetanakis NI, Duroux-Richard I, Unterluggauer JJ, Golob-Schwarzl N, Regeard C, Uzan C, Gouy S, DuBow M, Haybaeck J, Apparailly F, Busson P, Hildebrandt N.

Chem Sci. 2018 Sep 11;9(42):8046-8055. doi: 10.1039/c8sc03121e. eCollection 2018 Nov 14.

3.

The microglial reaction signature revealed by RNAseq from individual mice.

Hirbec H, Marmai C, Duroux-Richard I, Roubert C, Esclangon A, Croze S, Lachuer J, Peyroutou R, Rassendren F.

Glia. 2018 May;66(5):971-986. doi: 10.1002/glia.23295. Epub 2018 Feb 5.

PMID:
29399880
4.

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study.

Gagez AL, Duroux-Richard I, Leprêtre S, Orsini-Piocelle F, Letestu R, De Guibert S, Tuaillon E, Leblond V, Khalifa O, Gouilleux-Gruart V, Banos A, Tournilhac O, Dupuis J, Jorgensen C, Cartron G, Apparailly F.

Haematologica. 2017 Apr;102(4):746-754. doi: 10.3324/haematol.2016.153189. Epub 2017 Jan 25.

5.

X-Linked miRNAs Associated with Gender Differences in Rheumatoid Arthritis.

Khalifa O, Pers YM, Ferreira R, Sénéchal A, Jorgensen C, Apparailly F, Duroux-Richard I.

Int J Mol Sci. 2016 Nov 8;17(11). pii: E1852.

6.

CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.

Duroux-Richard I, Giovannangeli C, Apparailly F.

Joint Bone Spine. 2017 Jan;84(1):1-4. doi: 10.1016/j.jbspin.2016.09.012. Epub 2016 Nov 4. Review. No abstract available.

PMID:
27825565
7.

Effects of alcohol withdrawal on monocyte subset defects in chronic alcohol users.

Donnadieu-Rigole H, Mura T, Portales P, Duroux-Richard I, Bouthier M, Eliaou JF, Perney P, Apparailly F.

J Leukoc Biol. 2016 Nov;100(5):1191-1199. Epub 2016 Jun 2.

PMID:
27256567
8.

miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics.

Duroux-Richard I, Roubert C, Ammari M, Présumey J, Grün JR, Häupl T, Grützkau A, Lecellier CH, Boitez V, Codogno P, Escoubet J, Pers YM, Jorgensen C, Apparailly F.

Blood. 2016 Dec 29;128(26):3125-3136. doi: 10.1182/blood-2016-02-697003. Epub 2016 Oct 4.

9.

MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers.

Duroux-Richard I, Cuenca J, Ponsolles C, Piñeiro AB, Gonzalez F, Roubert C, Areny R, Chea R, Pefaur J, Pers YM, Figueroa FE, Jorgensen C, Khoury M, Apparailly F.

Int J Mol Sci. 2015 Jul 27;16(8):16953-65. doi: 10.3390/ijms160816953.

10.

Identification of polarized macrophage subsets in zebrafish.

Nguyen-Chi M, Laplace-Builhe B, Travnickova J, Luz-Crawford P, Tejedor G, Phan QT, Duroux-Richard I, Levraud JP, Kissa K, Lutfalla G, Jorgensen C, Djouad F.

Elife. 2015 Jul 8;4:e07288. doi: 10.7554/eLife.07288.

11.

Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis.

Duroux-Richard I, Pers YM, Fabre S, Ammari M, Baeten D, Cartron G, Touitou I, Jorgensen C, Apparailly F.

Mediators Inflamm. 2014;2014:342524. doi: 10.1155/2014/342524. Epub 2014 Mar 20.

12.

Transcriptomic network support distinct roles of classical and non-classical monocytes in human.

Anbazhagan K, Duroux-Richard I, Jorgensen C, Apparailly F.

Int Rev Immunol. 2014 Nov-Dec;33(6):470-89. doi: 10.3109/08830185.2014.902453. Epub 2014 Apr 14. Review.

PMID:
24730730
13.

The role of miR-155 in regulatory T cells and rheumatoid arthritis.

Spoerl D, Duroux-Richard I, Louis-Plence P, Jorgensen C.

Clin Immunol. 2013 Jul;148(1):56-65. doi: 10.1016/j.clim.2013.03.010. Epub 2013 Mar 29. Review.

PMID:
23649045
14.

What do microRNAs mean for rheumatoid arthritis?

Duroux-Richard I, Jorgensen C, Apparailly F.

Arthritis Rheum. 2012 Jan;64(1):11-20. doi: 10.1002/art.30651. Review. No abstract available.

15.

miRNAs and rheumatoid arthritis - promising novel biomarkers.

Duroux-Richard I, Jorgensen C, Apparailly F.

Swiss Med Wkly. 2011 Mar 18;141:w13175. doi: 10.4414/smw.2011.13175. eCollection 2011.

16.

MicroRNAs as new player in rheumatoid arthritis.

Duroux-Richard I, Presumey J, Courties G, Gay S, Gordeladze J, Jorgensen C, Kyburz D, Apparailly F.

Joint Bone Spine. 2011 Jan;78(1):17-22. doi: 10.1016/j.jbspin.2010.06.003. Review.

17.

Cationic liposome formulations for RNAi-based validation of therapeutic targets in rheumatoid arthritis.

Presumey J, Duroux-Richard I, Courties G, Apparailly F.

Curr Opin Mol Ther. 2010 Jun;12(3):325-30. Review.

PMID:
20521221
18.

From stem cells to bone: phenotype acquisition, stabilization, and tissue engineering in animal models.

Gordeladze JO, Reseland JE, Duroux-Richard I, Apparailly F, Jorgensen C.

ILAR J. 2009;51(1):42-61. Review.

PMID:
20075497
19.

Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs.

Gordeladze JO, Djouad F, Brondello JM, Noël D, Duroux-Richard I, Apparailly F, Jorgensen C.

Acta Pharmacol Sin. 2009 Oct;30(10):1369-84. doi: 10.1038/aps.2009.143. Review.

20.

RNA interference-based gene therapy for successful treatment of rheumatoid arthritis.

Courties G, Presumey J, Duroux-Richard I, Jorgensen C, Apparailly F.

Expert Opin Biol Ther. 2009 May;9(5):535-8. doi: 10.1517/14712590902926089 . Review.

PMID:
19392574

Supplemental Content

Loading ...
Support Center